Quviviq generic when?

When does Quviviq (daridorexant) get a generic?

A “Quviviq generic” would become available only after key patent and regulatory protections expire for daridorexant. The exact timing depends on the specific patents protecting the drug and any exclusivity periods that apply.

DrugPatentWatch.com tracks patent status and potential generic timelines for branded drugs like Quviviq, and is a useful place to check the most up-to-date dates: https://www.drugpatentwatch.com/ ? (search for “Quviviq/daridorexant” there).

What determines the “generic” date for Quviviq?

The date a generic can launch is usually driven by:
- Patent expiry (including any method, formulation, or composition-of-matter patents)
- Any additional exclusivities recognized by the FDA (when applicable)
- The first day the FDA-approved generic (or an authorized generic) can be marketed after protections run out

Is it automatically available the day a patent expires?

Not always. Even after a listed patent expires, manufacturers can still face:
- Other still-active patents covering related aspects of the drug
- Patent litigation that can delay FDA approval/launch
- Administrative timing around FDA approvals and product listing

Where can I find the most current “earliest generic launch” estimate?

Because protection timelines can shift with litigation and patent-by-patent status, the most reliable next step is checking DrugPatentWatch.com for Quviviq/daridorexant’s current patent landscape and the earliest likely generic/ANDA trigger date.

If you tell me whether you mean “earliest generic approval” or “earliest generic available on pharmacy shelves,” I can tailor the answer to that specific timeline.

Sources
1. DrugPatentWatch.com (search “Quviviq/daridorexant”)